Advertisement
Letter to the Editor| Volume 16, ISSUE 12, P1100-1102, December 01, 2015

Prescribed Doses of Opioids in Long-Term Care Facilities

Published:October 28, 2015DOI:https://doi.org/10.1016/j.jamda.2015.09.005
      Recent reports have highlighted a rapid increase in opioid use in long-term care. Pitkälä et al
      • Pitkälä K.H.
      • Juola A.L.
      • Hosia H.
      • et al.
      Eight-year trends in the use of opioids, other analgesics, and psychotropic medications among institutionalized older people in Finland.
      reported the prevalence of regular opioid use increased from 12% to 23% in Finnish nursing homes between 2003 and 2011. Hanlon et al
      • Hanlon J.T.
      • Perera S.
      • Sevick M.A.
      • et al.
      Pain and its treatment in older nursing home hospice/palliative care residents.
      reported that 65% of US nursing home hospice or palliative care residents with any pain used opioids. However, neither of these studies investigated opioid doses. This is important, because opioids are associated with a range of dose-dependent adverse drug events (ADEs), including sedation, orthostatic hypotension, dizziness, cognitive impairment, constipation, and falls.
      • Weiner D.K.
      • Hanlon J.T.
      • Studenski S.A.
      Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly.
      Australian guidelines recommend not exceeding a 24-hour oral morphine equivalent (MEQ) dose of 100 mg for noncancer pain.

      Department of Health, Victoria. Drugs and Poisons Regulation in Victoria. Victorian Government, 2014. Available at: http://www.health.vic.gov.au/dpcs/expirydates.htm. Accessed July 21, 2015.

      Faculty of Pain Medicine. Recommendations regarding the use of opioid analgesics in patients with chronic non-cancer pain. Australian and New Zealand Anesthestics, 2015. Available at: http://www.fpm.anzca.edu.au/resources/professional-documents/documents/PM1%202010.pdf. Accessed July 21, 2015.

      Older people, including those with dementia, may be particularly susceptible to opioid ADEs. However, there is a paucity of data on prescribed opioid doses in long-term care. For this reason, we investigated the median and range of doses of different opioids prescribed to residents with and without dementia in Australian long-term care facilities.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pitkälä K.H.
        • Juola A.L.
        • Hosia H.
        • et al.
        Eight-year trends in the use of opioids, other analgesics, and psychotropic medications among institutionalized older people in Finland.
        J Am Med Dir Assoc. 2015; 16: 973-978
        • Hanlon J.T.
        • Perera S.
        • Sevick M.A.
        • et al.
        Pain and its treatment in older nursing home hospice/palliative care residents.
        J Am Med Dir Assoc. 2010; 11: 579-583
        • Weiner D.K.
        • Hanlon J.T.
        • Studenski S.A.
        Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly.
        Gerontology. 1998; 44: 217-221
      1. Department of Health, Victoria. Drugs and Poisons Regulation in Victoria. Victorian Government, 2014. Available at: http://www.health.vic.gov.au/dpcs/expirydates.htm. Accessed July 21, 2015.

      2. Faculty of Pain Medicine. Recommendations regarding the use of opioid analgesics in patients with chronic non-cancer pain. Australian and New Zealand Anesthestics, 2015. Available at: http://www.fpm.anzca.edu.au/resources/professional-documents/documents/PM1%202010.pdf. Accessed July 21, 2015.

        • Tan E.C.
        • Visvanathan R.
        • Hilmer S.N.
        • et al.
        Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: A cross-sectional, multisite, epidemiological study protocol.
        BMJ Open. 2014; 4: e005757
      3. Eastern Metropolitan Region. Opioid conversion ratio: Guide to practice 2013. Victoria, 2013. Available at: http://www.emrpcc.org.au/wp-content/uploads/2013/10/EMRPCC-Opioid-Conversion-2013-final.pdf. Accessed July 21, 2015.

        • Muijsers R.B.
        • Wagstaff A.J.
        Transdermal fentanyl: An updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
        Drugs. 2001; 61: 2289-2307
      4. Australian Pain Society. Pain in residential aged care facilities: Management strategies. Australia, 2005. Available at: http://www.apsoc.org.au/PDF/Publications/Pain_in_Residential_Aged_Care_Facilities_Management_Strategies.pdf. Accessed July 21, 2015.

        • Abdulla A.
        • Adams N.
        • Bone M.
        • et al.
        Guidance on the management of pain in older people.
        Age Ageing. 2013; 42: i1-57
        • Tan E.C.
        • Jokanovic N.
        • Koponen M.
        • et al.
        Prevalence of analgesic use and pain in people with and without dementia or cognitive impairment in aged care facilities: A systematic review and meta-analysis.
        Curr Clin Pharmacol. 2015; 10: 194-203
        • Veal F.C.
        • Bereznicki L.R.
        • Thompson A.J.
        • Peterson G.M.
        Pharmacological management of pain in Australian Aged Care Facilities.
        Age Ageing. 2014; 43: 851-856